These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23090226)

  • 41. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin.
    Stark K; Bienzle U; Vonk R; Guggenmoos-Holzmann I
    Int J Epidemiol; 1997 Dec; 26(6):1359-66. PubMed ID: 9447418
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence, risk factors and genotypes of hepatitis C virus infection among drug users, Central-Western Brazil.
    Lopes CL; Teles SA; Espírito-Santo MP; Lampe E; Rodrigues FP; Motta-Castro AR; Marinho TA; Reis NR; Silva AM; Martins RM
    Rev Saude Publica; 2009 Aug; 43 Suppl 1():43-50. PubMed ID: 19669064
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Cross Section Study to Determine the Prevalence of Antibodies against HIV Infection among Hepatitis B and C Infected Individuals.
    Flores GL; de Almeida AJ; Miguel JC; Cruz HM; Portilho MM; Scalioni Lde P; Marques VA; Lewis-Ximenez LL; Lampe E; Villar LM
    Int J Environ Res Public Health; 2016 Mar; 13(3):. PubMed ID: 26978383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy.
    Semaille C; Le Strat Y; Chiron E; Chemlal K; Valantin MA; Serre P; Caté L; Barbier C; Jauffret-Roustide M;
    Euro Surveill; 2013 Jul; 18(28):. PubMed ID: 23870097
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme.
    Chetwynd J; Brunton C; Blank M; Plumridge E; Baldwin D
    N Z Med J; 1995 Sep; 108(1007):364-6. PubMed ID: 7566775
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence, genotypes and risk factors associated with hepatitis C virus infection in hemodialysis patients in Campo Grande, MS, Brazil.
    Freitas SZ; da Cunha RV; Martins RM; Teles SA; Ibanhes ML; Motta-Castro AR
    Mem Inst Oswaldo Cruz; 2008 Jun; 103(4):405-8. PubMed ID: 18660998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin.
    Stark K; Schreier E; Müller R; Wirth D; Driesel G; Bienzle U
    Scand J Infect Dis; 1995; 27(4):331-7. PubMed ID: 8658065
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of hepatitis C in prisons: WASH-C surveillance linked to self-reported risk behaviours.
    Gore SM; Bird AG; Cameron SO; Hutchinson SJ; Burns SM; Goldberg DJ
    QJM; 1999 Jan; 92(1):25-32. PubMed ID: 10209669
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidemiological survey of hepatitis C in a region considered to have high prevalence: the state of Minas Gerais, Brazil.
    Gomide GPM; Melo CB; Santos VDS; Salge VD; Camargo FC; Pereira GA; Cabral SCO; Molina RJ; Oliveira CDCHB
    Rev Soc Bras Med Trop; 2019; 52():e20190202. PubMed ID: 31596352
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of HCV risk behaviors among prison inmates: tattooing and injection drug use.
    Peña-Orellana M; Hernández-Viver A; Caraballo-Correa G; Albizu-García CE
    J Health Care Poor Underserved; 2011 Aug; 22(3):962-82. PubMed ID: 21841290
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trends in HIV, hepatitis B and hepatitis C prevalence among Australian prisoners - 2004, 2007, 2010.
    Reekie JM; Levy MH; Richards AH; Wake CJ; Siddall DA; Beasley HM; Kumar S; Butler TG
    Med J Aust; 2014 Mar; 200(5):277-80. PubMed ID: 24641153
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
    Solomon SS; Mehta SH; Srikrishnan AK; Solomon S; McFall AM; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Lucas GM; Kumar MS; Sulkowski MS; Quinn TC
    Lancet Infect Dis; 2015 Jan; 15(1):36-45. PubMed ID: 25486851
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High prevalence of hepatitis C virus infection in the largest province of Pakistan.
    Idrees M; Lal A; Naseem M; Khalid M
    J Dig Dis; 2008 May; 9(2):95-103. PubMed ID: 18419643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence and correlates of hepatitis C virus infection among inmates entering the California correctional system.
    Ruiz JD; Molitor F; Sun RK; Mikanda J; Facer M; Colford JM; Rutherford GW; Ascher MS
    West J Med; 1999 Mar; 170(3):156-60. PubMed ID: 10214102
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HEPATITIS B AND C IN PREGNANT WOMEN ATTENDED BY A PRENATAL PROGRAM IN AN UNIVERSITARY HOSPITAL IN RIO DE JANEIRO, BRAZIL: RETROSPECTIVE STUDY OF SEROPREVALENCE SCREENING.
    Barros MMO; Ronchini KROM; Soares RLS
    Arq Gastroenterol; 2018; 55(3):267-273. PubMed ID: 30540090
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prevalence of human immunodeficiency virus and hepatitis C virus, and associated factors among injecting drug users in Catalonia].
    Huntington S; Folch C; González V; Meroño M; Ncube F; Casabona J
    Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):236-8. PubMed ID: 19695744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
    Miller ER; Bi P; Ryan P
    Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of antibiotics to hepatitis C in a population of intravenous drug users in Valencia, Spain, 1990-1992.
    Bolumar F; Hernandez-Aguado I; Ferrer L; Ruiz I; Aviño MJ; Rebagliato M
    Int J Epidemiol; 1996 Feb; 25(1):204-9. PubMed ID: 8666491
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low prevalence of hepatitis C virus antibody in men who have sex with men who do not inject drugs.
    Buffington J; Murray PJ; Schlanger K; Shih L; Badsgard T; Hennessy RR; Wood R; Weisfuse IB; Gunn RA
    Public Health Rep; 2007; 122 Suppl 2(Suppl 2):63-7. PubMed ID: 17542456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.